PRP

[PRODIZEN]

[ziksir / Reporter Kwak Han-bin] Prodizen, a cell therapy company, announced on the 13th that it will participate in the 2025 Jeongju Medical Association held at the convention hall of the Baekbeom Kimgu Memorial Hall on the 16th to introduce GFC+, which was launched last year.

The Korean Association of Pharmacists is an academic organization that deals with research and clinical practice related to intravenous (IV) and infusion treatment.

Medical experts from home and abroad will attend the event to share the latest research and treatments.

Prodizen plans to introduce GFC+'s technology at this conference and seek global market expansion through exchanges with medical staff.

The GFC+ introduced this time is designed to enable faster and simpler PRP extraction by applying an original plasma separation system.

Founded in 1998, Prodizen is the first company in Korea to develop PRP (autologous blood-rich plasma) tubes, and has been leading the industry by supplying PRP and BMC products for more than a decade.

In addition, it has obtained European CE certification and U.S. FDA certification, and is recognized for its technological prowess in the global market.

All Prodizen's products are produced at its subsidiary MediSarang's GMP (Good Drug Manufacturing and Quality Control Standards) facility, and it is expanding its product lineup to be applied to various treatments through continuous research and development.

In addition, it is actively pursuing overseas markets such as Asia, Europe, and North America.

A professional official said, "The product product product will contribute to increase efficiency of medical sites, so it will contribute to increase efficiency of medical sites."

"We will share the development of cells through this semester, and expand the influence of cell therapy technology."

"Our products will contribute to increasing the efficiency of the medical field by enabling rapid and accurate PRP extraction," a Prodizen official said. "We will share the development of cell therapy technology and expand our influence in the global market through this conference."

Source: Direct reading (https://www.ziksir.com )